Drug Database
Back to search

Canada· CA-DIN-02014076

CLINIMIX E

A lösungen zur parenteralen ernährung, kombinationen product containing l-lysine hydrochloride + l-isoleucine + l-valine + l-phenylalanine hydrochloride, registered in Canada by BAXTER CORPORATION. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA10

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedCLINIMIX EATCB05BA10REGISTER NO.CA-DIN-02014076PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about l-lysine hydrochloride + l-isoleucine + l-valine + l-phenylalanine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lösungen zur parenteralen ernährung, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA10 (lösungen zur parenteralen ernährung, kombinationen), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 7 of them publish a price we can compare per daily dose
Search lösungen zur parenteralen ernährung, kombinationen products by name

Lösungen zur parenteralen ernährung, kombinationen · ATC B05BA10

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
L-LYSINE HYDROCHLORIDE + L-ISOLEUCINE + L-VALINE + L-PHENYLALANINE HYDROCHLORIDE
Manufacturer
BAXTER CORPORATION
Country
Canada (CA)
ATC code
B05BA10
ATC class
Lösungen zur parenteralen Ernährung, Kombinationen
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

6 interactions on record for lösungen zur parenteralen ernährung, kombinationen.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lösungen zur parenteralen ernährung, kombinationen against other medicinesHow interaction checks work

Lösungen zur parenteralen ernährung, kombinationen · interactions on record

6 records

  • 2 severe
  • 4 moderate

Most severe, free to view

  • ErdafitinibL01EN01severe
  • ErdafitinibL01EX16severe
  • AmfetamineN06BA01moderate
  • DexamfetamineN06BA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under B05BA10

Lösungen zur parenteralen ernährung, kombinationen, as other registers publish it.

All lösungen zur parenteralen ernährung, kombinationen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0a3fe68f-d5f4-4d6a-a880-1483016bdf82
GET /v1/drugs/0a3fe68f-d5f4-4d6a-a880-1483016bdf82?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02014076",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "INTRAVENOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "B05BA10",
  "schedule": [
    "Ethical"
  ],
  "drug_code": "14075",
  "strengths": [
    "290 MG",
    "240 MG",
    "230 MG",
    "310 MG",
    "10 G",
    "1.04 G",
    "210 MG",
    "90 MG",
    "261 MG",
    "24 MG",
    "220 MG",
    "58.5 MG",
    "520 MG",
    "205 MG",
    "20 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "L-LYSINE HYDROCHLORIDE",
    "L-ISOLEUCINE",
    "L-VALINE",
    "L-PHENYLALANINE HYDROCHLORIDE",
    "DEXTROSE",
    "GLYCINE",
    "L-PROLINE",
    "TRYPTOPHAN",
    "METHIONINE",
    "POTASSIUM PHOSPHATE DIBASIC",
    "MAGNESIUM CHLORIDE",
    "L-LEUCINE HYDROCHLORIDE",
    "HISTIDINE",
    "SODIUM CHLORIDE",
    "L-ARGININE",
    "L-ALANINE",
    "SODIUM ACETATE",
    "L-THREONINE",
    "L-TYROSINE"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about lösungen zur parenteralen ernährung, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console